12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Update Il y a 4 ans
Reference: NCT00789035

Woman and Man

Extract

The objective is to investigate the efficacy, safety and pharmacokinetics of three different doses of BI 10773 compared to placebo given for 12 weeks in patients with type 2 diabetes mellitus with insufficient glycemic control. In addition an open-label metformin arm will be assessed


Inclusion criteria

  • Diabetes Mellitus, Type 2


Links